This seminar will discuss how a genomic variation found in patients with psychosis led to the identification of a role for GLDC in the modulation of excitatory neurotransmission and schizophrenia-like behaviors. Moreover, we will discuss approaches targeting mitochondria to reverse biochemical and behavioral deficits in mouse models of schizophrenia.